Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Cheryl Galt who wrote (26624)	11/18/1998 6:33:00 PM
From: Russian Bear	Read Replies (1) \| Respond to of 32384

Cheryl, It is safe to say that we all agree -- the use of photographs to make this decision was highly suspect. It serves as yet another reminder of rule #1 for biotech investors: the FDA has the blatant power to be just as capricious and illogical as it wishes to be. However, with the positive recommendation rendered, Panretin is almost certainly looking at an approval. Once that happens, no one will care what the advisory committee had to say. And so, the issue of the use of the photographs is largely moot, in my opinion. I really liked Peter's "goalpost/photographic replay" analogy, though. Take care, RB